Status:
WITHDRAWN
Imaging of Residual Tumor During Prostatectomy
Lead Sponsor:
Spectros Corporation
Collaborating Sponsors:
Vanderbilt University
Cornell University
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
Prostate Cancer is the most common cancer in men, affecting about as many men as women diagnosed with breast cancer, and killing about as many men per year as breast cancer kills women. The most comm...
Detailed Description
In this 5 year academic-industrial partnership to FDA approval, an experienced team and partners including Cornell, Vanderbilt, Intuitive Surgical, LI-COR, and Sand Hill Institute, will move a prostat...
Eligibility Criteria
Inclusion
- Diagnosis of Prostate Cancer
- Plan for Prostatectomy
- Signed informed consent
Exclusion
- Informed consent not obtained
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01173146
Start Date
December 1 2011
End Date
June 1 2015
Last Update
May 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University
Nashville, Tennessee, United States, 37203